Kailera Therapeutics, Inc. KLRA
Set alert
12.15 USD -0.71 -5.52%
At close
12.39 +0.24 +1.98%
Pre-market · Nov 3, 7:54 AM ET
11.96 Day range 13.02
9.76 52-week range 28.23
- YTD
- -53.27%
- 1 year
- -53.27%
- Open
- 12.94
- Prev close
- 12.86
- Mkt cap
- 1.58B
- Vol
- 881.43K
- Avg vol
- 1.04M
- EPS
- -4.51
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 11.96
- High
- 13.02
- Forward P/E
- -2.83
- Beta
- 0.00
- Short ratio
- 5.58
- Inst. own
- 90.55%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Dec 2, 2026
- 50-d avg
- 13.29
- 200-d avg
- 17.98
- 1y target
- 42.75
Analyst view
Consensus: none
Price target (mean) 42.75 +251.9% upside
Now 12.15
- Target (low)
- 30.00
- Target (mean)
- 42.75
- Target (high)
- 57.00
Ratings (0m) 6 6 buy · 0 hold · 0 sell
- Strong buy1
- Buy5
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 6
- 1 month ago 6
- 2 months ago 6
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -1.01 | -1.30 – -0.79 | 0.00 | 0.0% | 0 | 0.0% | 5 |
| Next quarter | -1.16 | -1.54 – -0.95 | 0.00 | 0.0% | 0 | 0.0% | 5 |
| Current year | -4.10 | -5.86 – -2.96 | 0.00 | 0.0% | 0 | 0.0% | 5 |
| Next year | -4.30 | -5.89 – -2.99 | -4.10 | -4.9% | 0 | 0.0% | 5 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| May 12, 2026 | Leerink Partners | Initiated | — | Outperform |
| May 12, 2026 | Jefferies | Initiated | — | Buy |
| May 12, 2026 | Evercore ISI Group | Initiated | — | Outperform |
| May 12, 2026 | JP Morgan | Initiated | — | Overweight |